Corvus Pharmaceuticals
CRVS
#7528
Rank
โ‚ฌ0.29 B
Marketcap
4,54ย โ‚ฌ
Share price
-5.41%
Change (1 day)
194.56%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -โ‚ฌ51.28 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ26.02 Million, an increase over its 2022 earnings that were of -โ‚ฌ39.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ51.28 Million97.15%
2023 -โ‚ฌ26.02 Million-34.57%
2022 -โ‚ฌ39.75 Million-4.47%
2021 -โ‚ฌ41.62 Million621.28%
2020 -โ‚ฌ5.77 Million-87.16%
2019 -โ‚ฌ44.92 Million-0.57%
2018 -โ‚ฌ45.17 Million-15.67%
2017 -โ‚ฌ53.57 Million53.03%
2016 -โ‚ฌ35.01 Million16.08%
2015 -โ‚ฌ30.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.13 Billion 137.10%๐Ÿ‡บ๐Ÿ‡ธ USA